Innovate Biopharmaceuticals, Inc. added to membership of Russell 3000®, 2000® and the Russell Microcap® Indexes
June 25, 2018 10:30 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 25, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc. (NASDAQ:INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and...
Innovate Biopharmaceuticals Announces Appointment of Saira Ramasastry to Board of Directors and Resignation of Anna Kazanchyan, M.D.
June 13, 2018 19:10 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 13, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Scheduled to Present at the Jefferies Global Healthcare Conference in New York on Friday, June 8, 2018, at 11:30AM
May 31, 2018 07:02 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., May 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Scheduled to Present at BIO 2018 Convention in Boston on Tuesday, June 5, 2018, at 4:45PM
May 22, 2018 08:01 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Celiac Disease KOL and Management Meetings around the Digestive Disease Week (DDW) conference on Monday, June 4, 2018, in Washington, D.C.
May 17, 2018 15:06 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Reports First Quarter 2018 Key Financial and Corporate Highlights
May 16, 2018 09:10 ET
|
Innovate Biopharmaceuticals, Inc
Further data on larazotide’s mechanism of action, dose response and pharmacology expected at DDW (June 2-5) in Washington D.C.Addition to senior management of June Almenoff, M.D., PhD. as COO and CMO...
Innovate Biopharmaceuticals Announces Acceptance of Two Abstracts for the Digestive Disease Week 2018 Conference
May 09, 2018 14:07 ET
|
Innovate Biopharmaceuticals, Inc
Highlighting the Dose Response and Mechanism of Action of Larazotide Acetate In large animals, larazotide replicated its mechanism of action by renormalizing the dysfunctional intestinal barrierIn...
Innovate Biopharmaceuticals, Inc. to Present at the H.C. Wainwright Annual Global Life Sciences Conference on April 9, 2018
April 05, 2018 06:03 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., April 05, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer
March 13, 2018 07:32 ET
|
Innovate Biopharmaceuticals, Inc
Dr. Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and from Furiex Pharmaceuticals, where as President and Chief Medical Officer, she oversaw the...
Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at the Cowen Healthcare Conference on March 13, 2018, Tuesday at 8:40 AM ET
March 07, 2018 07:32 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...